Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/7/25 20:05 | 1/3/25 | RNAC | Health | Drug | Pharmaceutical Preparations | Kurtoglu Metin | MD | O | CTO | 2 | S.dm | -427 | 23.03 | 0 | -19 | 62 | D | |||||||||||||||
1/7/25 20:05 | 1/3/25 | RNAC | Health | Drug | Pharmaceutical Preparations | Miljkovic Milos | MD | O | Chief Me | 1 | S.m | -32 | 16.78 | 0 | -2 | 35 | D | |||||||||||||||
1/7/25 20:05 | 1/3/25 | RNAC | Health | Drug | Pharmaceutical Preparations | Jewell Christopher M | MD | O | Chief Sc | 1 | S.m | -43 | 16.78 | 0 | -3 | 53 | D | |||||||||||||||
1/7/25 20:05 | 1/3/25 | RNAC | Health | Drug | Pharmaceutical Preparations | English Emily | MD | O | Chief Op | 1 | S.m | -30 | 16.78 | 0 | -2 | 40 | D | |||||||||||||||
1/7/25 20:04 | 1/3/25 | RNAC | Health | Drug | Pharmaceutical Preparations | Brunn Carsten | MD | DO | P,CEO | 1 | S.m | -290 | 16.78 | 0 | -17 | 204 | D | |||||||||||||||
1/7/25 20:04 | 1/3/25 | RNAC | Health | Drug | Pharmaceutical Preparations | Davis Blaine | MD | O | CFO | 1 | S.m | -134 | 16.78 | 0 | -8 | 95 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |